Eli Lilly’s stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook

Eli Lilly's stock soared Tuesday toward its biggest gain in more than 20 years, following a strong earnings report and upbeat outlook for its Mounjaro drug.